NCT03183076 is a NA clinical trial of modified adkins diet in Epilepsy, Drug Resistant, sponsored by Instituto Mexicano del Seguro Social.

Who is sponsoring NCT03183076?

NCT03183076 is sponsored by Instituto Mexicano del Seguro Social.

What drugs are being tested in NCT03183076?

Interventions in NCT03183076: modified adkins diet, Pharmacotherapy without diet.

What condition does NCT03183076 study?

NCT03183076 studies Epilepsy, Drug Resistant.

Is NCT03183076 still recruiting?

NCT03183076 is currently completed. Last updated 9 June 2017.

Last reviewed 2017-06-09 · How we verify

NCT03183076

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy

Completed NA Last updated 9 June 2017

What this trial tests

NA trial testing modified adkins diet in Epilepsy, Drug Resistant in 14 participants. Completed in 30 December 2016.

Timeline

1 September 2015

Primary endpoint
30 April 2016

30 December 2016

Quick facts

Lead sponsor	Instituto Mexicano del Seguro Social
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	14
Start date	1 September 2015
Primary completion	30 April 2016
Estimated completion	30 December 2016
Sites	1 location across Mexico

Drugs / interventions tested

modified adkins diet
Pharmacotherapy without diet — full drug profile →

Conditions studied

Epilepsy, Drug Resistant — all drugs for Epilepsy, Drug Resistant →

Sponsor

Instituto Mexicano del Seguro Social — full company profile →

Who can join

18 and older, any sex, with Epilepsy, Drug Resistant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Atkins Diet Modified (ADM) is the best alternative treatment for drug-resistant epilepsy, There is a high prevalence worldwide , especially in Latin American countries, including Mexico. Low income earners, many of which do not have a social security, must meet the high costs by Antiepileptic Drugs (AEDS), which in addition should be used in conjunction or combination therapy, because monotherapy is insufficient . The diet adkins makes some changes in the traditional food habits by others that are accessible and not necessarily expensive, whose mechanism allows for better control of the seizures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ketogenic diets for drug-resistant epilepsy.
Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. · · 2020 · cited 166× · PMID 32588435 · DOI 10.1002/14651858.cd001903.pub5

Verify or expand the search:

Other recruiting trials for Epilepsy, Drug Resistant

Currently open trials in the same condition.

NCT06719791 — Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE) · EARLY_PHASE1 · recruiting
NCT06436547 — Subiculum Electrical Stimulation for Temporal Lobe Epilepsy With Biliteral Hippocampus Sclerosis(SESTB) · NA · active not recruiting
NCT06248333 — Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy · NA · recruiting

Other Instituto Mexicano del Seguro Social trials

Trials by the same sponsor.

NCT07536009 — "Effectiveness of a Telerehabilitation Program Versus a Conventional Rehabilitation Program in Patients With Subacromial · NA · not yet recruiting
NCT06632184 — Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy · Phase 4 · active not recruiting
NCT07073846 — Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery. · Phase 4 · recruiting
NCT07406971 — Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke · Phase 2 · recruiting
NCT07134504 — Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03183076 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Mexicano del Seguro Social
Last refreshed: 9 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03183076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing